コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ppear to be a direct effect of leptin on the pancreatic alpha cell.
2 a-aminobutyric acid A receptor activation in pancreatic alpha cells.
3 B and in relation to glucose fluctuations in pancreatic alpha cells.
4 insulin and is specifically produced by the pancreatic alpha cells.
5 in certain areas of the brain as well as in pancreatic alpha cells.
6 were also observed in a line of transformed pancreatic alpha cells.
7 lucagon release via blockade of NaChs in the pancreatic alpha-cells.
8 hypoglycemia and dramatic hyperplasia of the pancreatic alpha-cells.
9 of proglucagon to mature active glucagon in pancreatic alpha-cells.
11 in inhibition of glucagon release from mouse pancreatic alpha cells and the somatostatin subtype-5 re
12 onflicting views of the relationship between pancreatic alpha-cells and beta-cells and seek to unders
13 he differential processing of proglucagon in pancreatic alpha-cells and intestinal L cells leads to p
15 asis, there are additional links between the pancreatic alpha-cells and the hepatocytes, often collec
16 poglycaemia stimulates glucagon release from pancreatic alpha-cells, and are involved in glucose upta
17 n NOD mice, inhibits glucagon secretion from pancreatic alpha-cells, and mimics other actions of the
21 ies descendants of renin-expressing cells as pancreatic alpha cells despite a lack of active renin ex
23 concluded that postprandial lipemia induces pancreatic alpha cell dysfunction characteristic of type
24 type 2 diabetes and, therefore, propose that pancreatic alpha cell dysfunction could be viewed, at le
27 We investigated whether TGR5 activation in pancreatic alpha cells enhances hyperglycemia-induced PC
28 le to cell type-specific features, revealing pancreatic alpha cell enrichment as the most statistical
30 ch as endothelial cells (telangiectasia) and pancreatic alpha-cells (fatty liver and diabetes), with
31 o acids, which triggers the proliferation of pancreatic alpha-cells, forming a liver-alpha-cell loop.
35 cagon and glucagon-like peptide-1 levels and pancreatic alpha cell hyperplasia, probably secondary to
36 eceptor (GCGR) causes hyperaminoacidemia and pancreatic alpha-cell hyperplasia, but the GCGR downstre
38 these data indicate that XBP1 deficiency in pancreatic alpha-cells induces altered insulin signaling
39 ow that ranolazine, via blockade of NaChs in pancreatic alpha-cells, inhibits their electrical activi
45 of NIPAL1 in alpha-TC6 glucagonoma cells (a pancreatic alpha-cell line) were similar to the observat
46 gon were co-expressed in either pituitary or pancreatic alpha cell lines, proglucagon processing was
47 mechanisms responsible for the regulation of pancreatic alpha cell mass and function are not complete
52 (SGLT2) inhibitors in glucagon secretion by pancreatic alpha-cells reported controversial results.
53 ctive of this study was to determine whether pancreatic alpha-cells respond to pregnancy and their co
55 ntify major homeodomain proteins involved in pancreatic alpha-cell-specific proglucagon expression, w
57 ogical conditions, glucagon is released from pancreatic alpha cells to elevate circulating glucose le